The AAEL000291 gene encodes the 16 kDa proteolipid subunit of the V-ATPase, a multisubunit proton pump. The recombinant form (UniProt ID: O16110) is expressed in E. coli with an N-terminal His-tag for purification . Key structural features include:
Amino Acid Sequence: A 157-residue protein with conserved transmembrane domains critical for proton channel formation .
Domains: Four transmembrane helices (residues 11–33, 56–76, 93–114, 132–152) .
The V-ATPase generates proton gradients across membranes, enabling:
Organelle Acidification: Critical for lysosomal function, protein degradation, and synaptic vesicle proton gradients .
Secondary Transport: Powers nutrient uptake (e.g., potassium ions in Malpighian tubules) via electrochemical coupling .
Viral Interactions: Modulates CHIKV and DENV infection by influencing endosomal pH and vesicular trafficking .
In Ae. aegypti, this subunit is implicated in midgut and salivary gland function, where V-ATPase activity supports blood meal digestion and ionoregulation . Proteomic studies reveal its involvement in oxidative phosphorylation and ribosome biogenesis during CHIKV infection .
Viral Pathogenesis: Used to investigate how V-ATPase inhibition affects arbovirus replication (e.g., Zika, dengue) .
Ion Transport: Functional assays in insect epithelia quantify proton-pumping efficiency under physiological stressors .
Drug Screening: Serves as a target for small-molecule inhibitors to disrupt mosquito-borne virus transmission .
Vaccine Research: Antigenic characterization to develop transmission-blocking vaccines .
Mass spectrometry (timsTOF Pro) and label-free quantification confirm identity and post-translational modifications .
Proteomic Regulation: CHIKV infection suppresses AAEL000291 expression at 24–48 hpi, correlating with attenuated oxidative phosphorylation .
Genetic Knockdown: Silencing AAEL000291 in Ae. aegypti reduces midgut acidification, impairing DENV-2 infection .
Evolutionary Conservation: Structural homology with human ATP6V0C (82% similarity) enables cross-species functional studies .
The V-type proton ATPase (V-ATPase) in A. aegypti, like in other organisms, consists of two major sectors: the membrane-integral V₀ domain (responsible for proton translocation) and the cytosolic V₁ domain (responsible for ATP hydrolysis). The 16 kDa proteolipid subunit (AAEL000291) forms part of the V₀ domain's proteolipid ring, which is crucial for proton transport .
The complete V-ATPase complex consists of:
| Domain | Subunits |
|---|---|
| V₀ (membrane) | Subunits a, c, c", d, e |
| V₁ (cytosolic) | Subunits A through H |
The proteolipid ring in V₀ was initially thought to contain six proteolipids, but recent research in yeast and mammals suggests it contains ten proteolipids with conserved glutamic acid residues that serve as proton-binding sites in a flexible transmembrane helix .
RNA-Seq comparisons between larval and adult Malpighian tubules show significant developmental regulation of V-ATPase subunits. While specific data for AAEL000291 shows moderate expression levels (1.2 ± 0.1) in 9 out of 12 samples analyzed, many V-ATPase subunits demonstrate higher expression in larval stages compared to adults .
Comparative expression data from Malpighian tubules:
| Protein | Gene ID | Adult/Larval Fold Change | P-value |
|---|---|---|---|
| V-ATPase catalytic subunit A | AAEL008787 | 0.34 (2.96× higher in larvae) | <0.001 |
| V-type proton ATPase 16 kDa proteolipid subunit | AAEL010139 | Variable (16.9 ± 28.8) | Not reported |
| Vacuolar ATP synthase subunit H | AAEL000291 | Moderate (1.2 ± 0.1) | Not reported |
This developmental regulation may reflect the changing osmoregulatory needs throughout the mosquito lifecycle .
For successful recombinant expression of AAEL000291, a multi-step approach is recommended:
Expression system selection: E. coli systems often yield inclusion bodies requiring refolding. For functional studies, insect cell systems (Sf9, High Five) are preferred as they provide proper post-translational modifications and membrane insertion.
Construct design:
Include a cleavable N-terminal tag (His₆ or Strep-tag II) for purification
Consider a fusion protein approach (MBP or SUMO) to enhance solubility
Include TEV protease sites for tag removal post-purification
Expression optimization:
Functional verification: Reconstitute purified protein into proteoliposomes to verify proton transport activity using methods similar to those described for V-ATPase activity assessment in isolated membrane vesicles .
V-ATPase activity can be measured through several complementary approaches:
ATP hydrolysis assay: Use an enzymatic coupled assay where ATP hydrolysis is linked to NADH oxidation, measured as a decrease in absorbance at 340 nm. V-ATPase-specific activity is determined by the sensitivity to 100 nM concanamycin A (a specific V-ATPase inhibitor) .
Proton transport assay: Measure ATP-dependent proton transport in purified vacuolar membrane vesicles using pH-sensitive fluorescent dyes like ACMA (9-amino-6-chloro-2-methoxyacridine) or pyranine.
Membrane fractionation protocol:
Homogenize tissues in buffer containing 250 mM sucrose, 10 mM HEPES, 1 mM EDTA, pH 7.5
Perform differential centrifugation (1,000g → 10,000g → 100,000g)
Purify vacuolar membranes using Ficoll density gradient centrifugation
Verify enrichment by Western blotting using antibodies against the V₁A subunit
| Fraction | V-ATPase Activity (μmol ATP/min/mg) | Concanamycin A-Sensitive Activity (%) |
|---|---|---|
| Crude homogenate | 0.5-1.0 | 20-30 |
| Vacuolar membranes | 3.0-5.0 | 70-90 |
In Malpighian tubules of A. aegypti, the V-ATPase provides the primary energetic drive for both transcellular and paracellular ion transport . The proteolipid subunit is critical to this function as it forms the actual proton channel through the membrane.
The physiological role involves:
Primary active transport: V-ATPase establishes an electrochemical proton gradient across the apical membrane of principal cells in Malpighian tubules.
Secondary transport: This gradient drives secondary ion transport processes including:
Systemic integration: The V-ATPase-driven ion transport in Malpighian tubules coordinates with neuroendocrine signals to maintain hemolymph homeostasis in response to blood-feeding and environmental challenges .
The AAEL000291 protein contains several distinctive structural elements compared to homologs in other species:
Conserved glutamic acid residue: Like all V-ATPase proteolipid subunits, AAEL000291 contains a critical conserved glutamic acid residue in the fourth transmembrane helix that serves as the proton-binding site.
Transmembrane topology: The protein features four transmembrane α-helices with both N- and C-termini facing the cytoplasmic side.
Species-specific variations: Sequence alignment with proteolipid subunits from other insects reveals higher conservation in the transmembrane domains than in the connecting loops, suggesting functional constraints on the membrane-spanning regions.
Post-translational modifications: Multiple phosphorylation sites have been identified, particularly on serine and threonine residues in the cytoplasmic loops, which may regulate assembly or activity .
For effective subcellular localization studies:
Immunofluorescence microscopy:
Fix tissues in 4% paraformaldehyde
Permeabilize with 0.1% Triton X-100
Block with 3% BSA
Incubate with primary antibodies against AAEL000291 (1:1000 dilution)
Detect with fluorescent secondary antibodies (1:500)
Counterstain with DAPI for nuclei and phalloidin for F-actin
Image using confocal microscopy
Subcellular fractionation:
Separate membrane fractions by differential centrifugation
Analyze protein distribution by Western blotting
Use markers for different compartments: Na⁺/K⁺-ATPase (plasma membrane), calnexin (ER), GM130 (Golgi)
Electron microscopy:
Process tissues for transmission electron microscopy
Perform immunogold labeling using antibodies against AAEL000291
Quantify gold particle distribution across different membrane compartments
For effective RNAi-mediated knockdown:
dsRNA design:
Target a 300-500 bp region specific to AAEL000291
Avoid regions with sequence similarity to other genes
Design using E-RNAi or DEQOR software to minimize off-target effects
Include dsRNA targeting GFP or LacZ as negative controls
Delivery methods:
Microinjection: Inject 500-1000 ng dsRNA into the thorax of adult female mosquitoes
Feeding: Mix dsRNA with blood meal (10 μg/ml) supplemented with a transfection reagent
Cell culture: Transfect A. aegypti-derived cells (Aag2) with dsRNA using Lipofectamine
Validation of knockdown:
Measure AAEL000291 mRNA levels by RT-qPCR 3-5 days post-treatment
Assess protein reduction by Western blotting
Evaluate functional consequences by measuring V-ATPase activity
| Delivery Method | Knockdown Efficiency (%) | Duration of Effect (days) | Technical Difficulty |
|---|---|---|---|
| Microinjection | 70-90 | 7-10 | High |
| Feeding | 40-60 | 3-5 | Low |
| Cell culture | 80-95 | 2-4 | Medium |
When facing contradictory expression data:
Methodological comparison:
Compare RNA extraction and quality assessment methods
Evaluate normalization strategies (housekeeping genes vs. global normalization)
Assess technical vs. biological replication
Biological variables to consider:
Mosquito strain differences (laboratory vs. field-collected)
Developmental stage precision (hours post-eclosion matters)
Blood-feeding status (significant transcriptional changes occur post-blood meal)
Sex differences (male vs. female expression patterns)
Tissue-specific expression patterns
Integrated analysis approach:
Combine RNA-Seq, microarray, and RT-qPCR data
Weight results based on methodological rigor
Consider meta-analysis approaches for multiple datasets
Validate key findings with independent biological samples
Studies have shown considerable variation in V-ATPase subunit expression between developmental stages, with the catalytic subunit A showing 2.96× higher expression in larvae compared to adults , which could explain some contradictory findings if developmental staging was imprecise.
For evolutionary analysis of AAEL000291:
Sequence-based approaches:
Multiple sequence alignment using MUSCLE or MAFFT
Phylogenetic tree construction using maximum likelihood (RAxML or IQ-TREE)
Selection analysis using PAML to identify sites under positive or purifying selection
Ancestral sequence reconstruction to trace the evolution of key residues
Structure-based analyses:
Homology modeling based on existing V-ATPase structures
Molecular dynamics simulations to assess functional impacts of evolutionary changes
Protein-protein interaction interface analysis across species
Comparative genomics:
Synteny analysis to examine gene order conservation
Analysis of selection pressures using dN/dS ratios
Investigation of gene duplication events in the V-ATPase family
Population genomics:
Analysis of single nucleotide polymorphisms in AAEL000291 across A. aegypti populations
Assessment of geographic variation and adaptive evolution
Correlation with insecticide resistance or vector competence phenotypes
The relationship between V-ATPase function and vector competence involves several mechanisms:
pH regulation during viral infection:
V-ATPase activity modulates endosomal pH, which is critical for dengue virus fusion and entry
Transcriptomic data shows differential expression of V-ATPase subunits in dengue-infected mosquitoes compared to uninfected controls
Several genes associated with proteolysis (including some regulated by pH) show significant differences between infected and uninfected mosquitoes
Immune response modulation:
V-ATPase-dependent acidification impacts immune signaling pathways
Dengue-infected mosquitoes show differential expression of chromatin-associated genes, proteases, and immunity-related factors that may interact with V-ATPase function
Specific immunity-related transcripts like CTLMA12, cathepsin B, and holotricin show increased abundance in dengue-infected mosquitoes
Tissue-specific implications:
Midgut V-ATPase function influences the initial steps of viral infection
Salivary gland V-ATPase activity may impact viral transmission
Malpighian tubule V-ATPase affects systemic homeostasis during infection
Cutting-edge approaches for studying V-ATPase dynamics include:
Real-time imaging techniques:
FRET-based biosensors to monitor V-ATPase subunit interactions
pH-sensitive GFP variants to visualize compartment acidification in real-time
Photoactivatable and photoconvertible fluorescent proteins to track subunit movement
Cryo-electron microscopy:
Single-particle cryo-EM to determine high-resolution structures of different assembly states
Cryo-electron tomography of cellular sections to visualize V-ATPase in its native environment
Time-resolved cryo-EM to capture intermediate assembly states
Mass spectrometry approaches:
Crosslinking mass spectrometry to map subunit interfaces
Hydrogen-deuterium exchange mass spectrometry to identify dynamic regions
Quantitative proteomics to measure assembly/disassembly kinetics
Genetic approaches:
CRISPR-Cas9 genome editing to create tagged V-ATPase subunits at endogenous loci
Optogenetic tools to control V-ATPase assembly/disassembly
Single-cell transcriptomics to identify cell-specific regulation patterns
These technologies provide unprecedented insights into the dynamic regulation of V-ATPase assembly and disassembly in response to environmental cues and developmental signals.
When facing purification challenges:
Solubilization optimization:
Test different detergents (DDM, LMNG, GDN) at various concentrations
Include lipids (cholesterol, POPC) during solubilization
Use mild extraction conditions (lower temperature, gentler agitation)
Purification refinements:
Implement gradient elution protocols to improve separation
Add stabilizing agents (glycerol, specific lipids) to all buffers
Consider amphipol or nanodisc reconstitution for increased stability
Use size-exclusion chromatography as a final polishing step
Functional assessment:
Develop sensitive activity assays compatible with detergent-solubilized protein
Implement reconstitution into proteoliposomes for functional studies
Use thermal stability assays to identify optimal buffer conditions
Co-expression strategies:
To distinguish direct from indirect effects:
Complementary approaches:
Combine genetic knockdown with rescue experiments using RNAi-resistant constructs
Use pharmacological inhibitors with different mechanisms of action
Employ rapid inducible systems to observe immediate vs. delayed effects
Biochemical validation:
Perform in vitro reconstitution with purified components
Use site-directed mutagenesis to create separation-of-function mutants
Conduct interaction studies with purified proteins to verify direct associations
Temporal analysis:
Implement time-course experiments to establish sequence of events
Use rapid inhibition techniques (photocaged inhibitors, optogenetics)
Correlate phenotypic changes with molecular events using synchronized assays
System-level integration:
Develop mathematical models to predict direct vs. network effects
Use multi-omics approaches to identify immediate targets and downstream effects
Compare effects across different cellular contexts and genetic backgrounds
These strategies enable more precise attribution of observed phenotypes to direct AAEL000291 function versus secondary cellular responses.
| Subunit | Gene ID | Malpighian Tubules (FPKM) | Midgut (FPKM) | Salivary Glands (FPKM) |
|---|---|---|---|---|
| V-ATPase subunit H | AAEL000291 | 1.2 ± 0.1 | Not reported | Not reported |
| V-type proton ATPase 16 kDa proteolipid | AAEL010139 | 16.9 ± 28.8 | Not reported | Not reported |
| Catalytic subunit A | AAEL008787 | Larval: ~3× higher than adult | Variable | Variable |
| Residue | Conservation | Function | Effect of Mutation |
|---|---|---|---|
| Glu139* | Universal | Proton binding | Loss of proton transport |
| Arg59* | High | Stabilizes helix packing | Impaired assembly |
| Ser22* | Moderate | Phosphorylation site | Altered regulation |
| Gly34* | High | Helix flexibility | Rigid structure, impaired rotation |
*Hypothetical positions based on conserved features of V-ATPase proteolipid subunits